 |
(3S)-(+)-(5-chloro-2-methoxyphenyl)-1,3-dihydro-3-fluoro-6-(trifluoromethyl)-2H-indol-2-one |
|---|---|
| Trade Name | |
| Orphan Indication | Fragile X syndrome |
| USA Market Approval | USA |
| USA Designation Date | 2015-12-09 00:00:00 |
| Sponsor | Centre National de la Recherche Scientifique (CNRS);3 Rue Michel-Ange;Paris |
